Skip to main content
Fig. 5 | Cancer Cell International

Fig. 5

From: Activating transcription factor 5 (ATF5) promotes tumorigenic capability and activates the Wnt/b-catenin pathway in bladder cancer

Fig. 5

ATF5 expression associated with Wnt/β-catenin signaling stimulation in BLCA. A qRT-PCR assay of DVL1 and WB detection of DVL1, ATF5 and the active-β-catenin in eight fresh BLCA specimens; GAPDH was used as a loading control. B–E Association analyses of ATF5 expression with expression of DVL1 and the active-β-catenin in eight fresh BLCA specimens. qRT-PCR, quantitative real-time polymerase chain reaction; WB, western blotting; DVL1, dishevelled segment polarity protein 1; BLCA, bladder urothelial carcinoma

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us